| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2973530 | The Journal of Heart and Lung Transplantation | 2005 | 7 Pages |
Abstract
C2 monitoring allows a significant cyclosporine dose reduction without compromising patient outcome in stable heart transplant patients. Further studies are required to ascertain whether this dose reduction can be translated into clinical benefit.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Helen C. (FRCS), Farük (FRCS), Malcolm B. (FRCS), William BSc, Carol RGN, Myra RGN, Jane RGN, Andrew J. (FRCS),